These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 13700039)

  • 1. [Protective role of placenta and embryo against the development of "infarctoid cardiopathy" in rats].
    FITKO R
    Pol Tyg Lek; 1960 Aug; 15():1297-9. PubMed ID: 13700039
    [No Abstract]   [Full Text] [Related]  

  • 2. Protection by pregnancy against the development of "infarctoid cardiopathy" and nephrocalcinosis.
    SELYE H
    J Obstet Gynaecol Br Emp; 1958 Aug; 65(4):588-9. PubMed ID: 13576236
    [No Abstract]   [Full Text] [Related]  

  • 3. Protection by KCI against the syndrome of acute infarctoid cardiopathy with nephrocalcinosis.
    SELYE H; RENAUD S
    Exp Med Surg; 1957; 15(4):335-40. PubMed ID: 13512336
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of methylmercury on glutamate-cysteine ligase expression in the placenta and yolk sac during mouse development.
    Díaz D; Krejsa CM; White CC; Charleston JS; Kavanagh TJ
    Reprod Toxicol; 2004 Nov; 19(1):117-29. PubMed ID: 15336720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insight into early pregnancy events: the emerging role of the embryo.
    Barnea ER
    Am J Reprod Immunol; 2004 May; 51(5):319-22. PubMed ID: 15212665
    [No Abstract]   [Full Text] [Related]  

  • 6. Protection by potassium against the syndrome of infarctoid cardiopathy induced by combined treatment with 2(alpha)methyl-9(alpha)-chlorocortisol and phosphate.
    MISHRA RK
    Indian J Med Res; 1958 Jul; 46(4):597-602. PubMed ID: 13574850
    [No Abstract]   [Full Text] [Related]  

  • 7. Functional significance of developmental changes in placental microvascular architecture.
    Reynolds LP; Biondini ME; Borowicz PP; Vonnahme KA; Caton JS; Grazul-Bilska AT; Redmer DA
    Endothelium; 2005; 12(1-2):11-9. PubMed ID: 16036313
    [No Abstract]   [Full Text] [Related]  

  • 8. [Induction of an infarctoid cardiopathy in golden hamsters].
    DE SALCEDO I
    Rev Clin Esp; 1958 Jan; 68(1):33-5. PubMed ID: 13542917
    [No Abstract]   [Full Text] [Related]  

  • 9. Blocking of the placental immune-modulatory ferritin activates Th1 type cytokines and affects placenta development, fetal growth and the pregnancy outcome.
    Nahum R; Brenner O; Zahalka MA; Traub L; Quintana F; Moroz C
    Hum Reprod; 2004 Mar; 19(3):715-22. PubMed ID: 14998975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rat visceral yolk sac (VYS) and placenta mitochondrial features during the placentation period.
    Alcolea MP; Colom B; Amengual-Cladera E; Lladó I; Gianotti M; García-Palmer FJ
    Mitochondrion; 2008 Dec; 8(5-6):389-95. PubMed ID: 18824141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct expression and localization of serine protease HtrA1 in human endometrium and first-trimester placenta.
    Nie G; Hale K; Li Y; Manuelpillai U; Wallace EM; Salamonsen LA
    Dev Dyn; 2006 Dec; 235(12):3448-55. PubMed ID: 17072861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical period for a teratogenic VLA-4 antagonist: Developmental effects and comparison of embryo drug concentrations of teratogenic and non-teratogenic VLA-4 antagonists.
    Crofts F; Rohatagi S; Pino M; DeLise B; Zhang J; Nguyen M; Guittin P; Barbellion S; Brunel P; Hofmann T; Schmidt J; Wong M; Lockey P; Lerman S; Clark R
    Birth Defects Res B Dev Reprod Toxicol; 2004 Apr; 71(2):69-79. PubMed ID: 15098200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophages and apoptotic cell clearance during pregnancy.
    Abrahams VM; Kim YM; Straszewski SL; Romero R; Mor G
    Am J Reprod Immunol; 2004 Apr; 51(4):275-82. PubMed ID: 15212680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptosis and human placenta: expression of proteins belonging to different apoptotic pathways during pregnancy.
    De Falco M; Penta R; Laforgia V; Cobellis L; De Luca A
    J Exp Clin Cancer Res; 2005 Mar; 24(1):25-33. PubMed ID: 15943028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of parathyroid hormone like hormone (PTHLH) antagonist, PTHLH(7-34), on fetoplacental development and growth during midgestation in rats.
    Thota CS; Reed LC; Yallampalli C
    Biol Reprod; 2005 Dec; 73(6):1191-8. PubMed ID: 16093356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of high deprenyl dose on the preimplantation embryo development and lymphocyte DNA in rat.
    Mihalik J; Kravcuková P; Spakovská T; Mareková M; Schmidtová K
    Gen Physiol Biophys; 2008 Jun; 27(2):121-6. PubMed ID: 18645227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of calcitonin and parathyroid hormone on the regulation of cabindin-D(9k) in the uterus, placenta, and fetal membrane of rats related to blood calcium level during late gestation.
    Hong EJ; Choi KC; Hyun SH; Jeung EB
    Mol Reprod Dev; 2007 Sep; 74(9):1188-97. PubMed ID: 17410547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adrenal cortical hormone-like substance extracted from the placenta (P.C. substance).
    SAWASAKI C; KAGAYAMA M; NIINOBE S; SUGAWARA S
    J Jpn Obstet Gynecol Soc; 1954 Apr; 1(2):158-79. PubMed ID: 14381695
    [No Abstract]   [Full Text] [Related]  

  • 19. Cytokine networks in the establishment and maintenance of pregnancy.
    Orsi NM
    Hum Fertil (Camb); 2008 Dec; 11(4):222-30. PubMed ID: 19085258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does the physiological acromegaly of pregnancy benefit the fetus?
    Verhaeghe J
    Gynecol Obstet Invest; 2008; 66(4):217-26. PubMed ID: 18645254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.